🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

RGEN RGEN

Company Profile ↓
$158.59
+36.13% 1Y
Mkt Cap$8.93B
P/E184.41
P/B4.24
52W High$172.26
52W Low$102.87
Book Value$37.39
EPS (TTM)$0.86

Company Overview

RGEN (RGEN) is a publicly traded company listed on with a market capitalization of $8.93B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 26.8% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.33.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $738.26M (+16.4% YoY); net profit $48.89M.
  • Trailing 12 Months Year-on-year growth — revenue +16.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 26.8%, profit CAGR -4.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:26.80%
1 Year:16.36%

Compounded Profit Growth

5 Years:-3.99%
1 Year:-

Stock Price Performance

1 Year:+36.13%
6 Months:+5.56%
3 Months:+26.26%
1 Month:+13.42%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 80% of range
$102.87 $172.26
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)66.08 · Neutral
Price Performance
1M+13.42%
3M+26.26%
6M+5.56%
1Y+36.13%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 26.8% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading at a high P/E of 184.4.
  • Earnings shrank at -4.0% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
184.41
Industry PE
-
Forward P/E est.
158.48
PEG Ratio
-
Book Value
$37.39
Price to Book
4.24
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
26.80%
Profit 5Y
-3.99%
Revenue (YoY)
16.36%
Earnings (YoY)
-

Profitability & Returns

ROCE
1.48%
ROE
2.32%
ROA
1.66%
Profit Margin
6.62%
Op Margin
5.63%
Gross Margin
52.32%
EPS (Latest Qtr)
$0.09
EPS (TTM)
$0.86

Balance Sheet & Liquidity

Debt/Equity
0.33
Quick Ratio
7.12
Current Ratio
8.37
Debt
$689.95M
Total Assets
$2.95B
Current Assets
$1.20B
Working Capital
$1.00B

Ownership

Promoter Holding
5.24%
Chg in Prom Hold
0.00%
FII / Inst Holding
120.12%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$738.26M
EBITDA
$180.85M
Free Cash Flow
$91.69M
Operating Cash Flow
$117.42M
Shares Outstanding
56.33M
Gross Margin
52.32%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue 19.81M21.45M25.09M29.17M24.68M25.60M30.59M32.45M36.58M41.61M44.83M------------------------182.37M188.81M197.91M194.25M204.13M
Cost of Revenue -----------------------------------89.37M88.29M94.08M85.97M94.09M
Gross Profit ------16.60M18.52M16.59M22.48M25.16M26.64M27.35M28.35M33.79M39.98M38.02M39.35M44.11M50.60M54.43M60.48M-------------93.00M100.52M103.83M108.28M110.04M
Operating Expenses -----------------------------------84.88M87.84M87.48M90.99M91.03M
Operating Income 3.69M1.43M3.46M5.86M3.75M2.90M5.68M5.47M-406.00K3.26M5.98M4.27M7.89M-11.17M11.05M7.96M-11.91M19.54M20.96M-36.38M48.24M45.19M60.00M63.17M52.66M31.26M19.40M4.69M3.75M5.47M-7.83M-8.12M12.68M16.35M17.29M19.00M
EBITDA -----------------------------------48.34M46.94M49.20M31.89M43.59M
Interest Expense -----------------------------------5.35M5.41M5.50M5.58M5.66M
Pretax Income -----------------------------------18.21M17.11M19.11M1.77M14.15M
Tax Provision -----------------------------------3.35M2.20M5.83M-6.56M9.14M
Net Income 2.54M265.00K1.62M3.87M1.16M5.03M3.07M8.44M4.67M12.18M3.45M2.74M4.79M5.64M8.05M8.10M1.66M3.60M9.81M15.86M14.55M19.70M29.45M36.23M33.50M46.96M49.86M40.41M28.83M20.06M16.92M3.30M5.71M-654.00K-14.87M14.91M13.29M8.33M5.01M
Diluted EPS 0.080.010.050.110.030.150.090.240.110.270.080.060.100.120.170.170.030.070.180.300.270.360.520.640.580.810.880.710.510.350.300.060.10-0.01-0.260.260.230.150.09
R&D Expense 1.49M1.43M1.54M1.89M1.89M2.04M1.74M1.86M2.00M3.07M3.29M5.78M3.60M-3.62M5.23M5.43M-4.70M4.34M4.42M-7.61M8.39M9.15M12.15M10.44M10.23M12.15M9.71M10.58M11.24M10.57M9.71M12.11M13.97M14.18M-14.46M14.42M

Profit & Loss (Annual)

Figures in USD.

Metric Mar 2010Mar 2011Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 20.97M27.29M-62.27M68.17M63.55M83.54M104.54M141.24M194.03M270.25M366.26M670.53M801.54M632.36M634.44M738.26M
Cost of Revenue -------------345.83M353.92M359.79M352.01M
Gross Profit -------------455.71M278.44M274.64M386.25M
Operating Expenses -------------259.76M261.31M306.57M344.69M
Operating Income -5.77M-374.07K-11.08M22.87M10.69M13.76M15.97M14.01M25.99M36.08M69.82M167.25M195.94M17.13M-31.92M41.56M
EBITDA -------------277.31M145.32M80.26M180.85M
Interest Expense -------------1.16M2.50M20.73M21.51M
Pretax Income -------------219.14M56.71M-27.04M62.38M
Tax Provision -------------33.18M21.11M-1.52M13.49M
Net Income -4.06M-43.51K-1.61M14.16M16.09M8.17M9.35M11.68M28.35M16.62M21.41M59.93M128.29M185.96M35.60M-25.51M48.89M
Diluted EPS -0.130.00-0.450.500.250.280.340.720.370.441.112.243.240.74-0.460.86
R&D Expense 14.16M12.53M-10.49M7.34M5.61M5.74M7.36M8.67M15.82M19.45M20.18M34.27M43.94M42.72M43.20M54.18M

Balance Sheet (Annual)

Figures in USD.

Metric Mar 2009Mar 2010Dec 2010Mar 2011Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ---72.29M76.06M97.01M118.64M128.29M146.24M288.91M743.52M774.62M1.40B1.90B-2.53B2.83B2.83B2.95B
Current Assets ---------------998.12M1.11B1.07B1.14B
Cash & Equivalents 5.04M12.53M9.79M14.20M11.17M29.21M39.83M35.36M54.09M122.23M173.76M193.82M528.39M717.29M-523.46M751.32M757.36M566.02M
Inventory ---------------238.28M202.32M142.96M170.46M
Receivables ---------------116.25M124.16M134.12M158.59M
Total Liabilities ----------151.97M159.05M340.35M373.74M-620.90M866.34M856.95M843.57M
Current Liabilities ---4.62M7.46M10.75M11.30M10.68M18.78M21.07M25.21M129.84M48.31M318.96M-404.20M164.94M126.79M135.83M
Long Term Debt ----------------510.14M525.57M542.21M
Total Debt ---------------422.96M711.80M686.25M689.95M
Total Equity 69.12M66.12M67.09M67.09M65.99M84.12M84.12M111.73M122.75M168.76M591.55M615.57M1.06B1.53B-1.91B1.96B1.97B2.11B
Shares Outstanding ---------------55.56M55.77M56.09M56.33M

Cash Flows (Annual)

Figures in USD.

Metric Mar 2010Mar 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -2.45M3.23M13.44M25.93M--7.52M17.45M32.77M67.22M62.62M-172.08M113.92M175.39M117.42M
Investing Cash Flow 9.92M-1.50M2.84M-17.91M---49.19M-98.70M-14.04M-205.31M-201.38M--233.24M-123.28M-86.38M-298.47M
Financing Cash Flow 11.59K-50.28K1.16M2.52M--112.11M129.94M3.41M484.87M305.92M--13.34M248.96M-82.90M-15.21M
Capital Expenditure -597.35K-524.67K-1.26M-4.63M-5.60M-2.63M-4.33M-5.45M-10.63M-18.50M-22.45M--133.35M-38.99M-32.91M-25.73M
Free Cash Flow -3.05M2.71M12.18M21.29M--3.20M12.00M22.14M48.71M40.17M-38.74M74.93M142.49M91.69M
Net Change in Cash -------------74.49M239.60M6.11M-196.26M
Share Buybacks -----------0014.39M00

Ratios (Annual)

Figures in %.

Metric Mar 2010Mar 2011Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------56.9%44.0%43.3%52.3%
Operating Margin % -27.5%-1.4%-17.8%33.6%16.8%16.5%15.3%9.9%13.4%13.4%19.1%24.9%24.4%2.7%-5.0%5.6%
Net Margin % -19.4%-0.2%-22.7%23.6%12.9%11.2%11.2%20.1%8.6%7.9%16.4%19.1%23.2%5.6%-4.0%6.6%
ROE % -6.1%-0.1%-2.4%16.8%19.1%7.3%7.6%6.9%4.8%2.7%2.0%3.9%-9.7%1.8%-1.3%2.3%
ROCE % --0.6%-12.8%21.3%9.1%10.8%6.0%1.9%4.0%2.7%4.4%-9.2%0.6%-1.2%1.5%

Shareholding Pattern

Insiders
5.24%
Institutions
120.12%
Public Float
126.77%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for RGEN

Google News Wed, 05 Aug 2026

Is It Too Late to Buy Repligen Corp (RGEN) After 5.8% Rally? GF Value Says Undervalued - GuruFocus

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNMGNYQnIwdFFjWmpPZEEybzFBamIwcW8zenVyVDJSV2wzNTFnTDd0enh6czdmWEZ1RTJSSHpOZkU5ME94SjBaemtVbkg2T0x4TFZLdmE4RUZZUnZwWUpGc3M2VDZKRmhtVkNaME1IQ0F1Tjc4UGhsNV9KS05jQ0xWdVk5c2VobXNfMnRveG…

Google News ue, 21 Jul 2026

Why Repligen (RGEN) Stock Is Trading Lower Today - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNUThmN1JPRE5nYVVjeUxFNnJ4b09yZ3Bqc2NkSENSVUVsNzRkQjZwQkk4UmdsRFY5aFFNQzhxQS1mTGk1X05DZDh5bUlTaFRSOUcyNHRxc1FiazdfakRyR01Sel9xci1DUFZQUTBlNnk2LUpFRHI1T3BpSXFKcnlmVTF5YlhMdFVodFRtc2…

Google News ue, 21 Jul 2026

Why Repligen (RGEN) Stock Is Down Today - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNUGhhQkJVazBoX0VfNDE3QkE1ekRrd1JKczhvSS1FOHlQTjAwMktXNGNsdjFua0pJVldoMVU1N1lTVEdnQ0tGbjlrWm0wWk0tNU11RWsySWJBcXpkV0JhbU5MX3J5RTc4TU1OSm1lUWlEcjdlSGlaZDRmMXZEeDg4bFF3?oc=5" target=…

Google News ue, 04 Aug 2026

Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQSkJhcElRV3k5VGo5S3lNb2dGcEFMdmdZZnlONHNUVUw2RlFKamFpNGxPV1FyM21qVlZnWVVqejd0dXVqTFZES09HckJwUkxicXZLanczSmRZTzlDUUZPRjMwaFY5bEcwV1RLb0MwenNTMHc2cjV3SGRoX0dXMWNGUjdscS1WY3BfVmhXMW…

Google News Wed, 29 Jul 2026

Repligen (RGEN) Stock Faces A Margin Puzzle After Revenue Growth - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxPUUEwNGxKenNDbWdBZjYzbUlEdkxuVmpQOHgyenpXV3MwaEJJcVRNT2phaF94OEZOejEta0daTmdkY0NmckxUTDF2UW83ZXdfR1JyVDBfU04yY0xXODFMekJER2JrYkxXZnU2RVkydm81X25UM0ZwWmVrVkx3OHZQUXNSNUp0NmdZc0RwYV…

Google News hu, 30 Jul 2026

Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup - ChartMill

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbFcycUNmT0s3YVV4QkU2ak5HVmlKazQ3bzFrLWZfUGNBSVpvcmM5dXpyT3VIXzBidHJIblNZY0ZSLURqS1pkbWljQkJKN251c19GZl8zWDhyNmNFMFgwUjY2dmZYbXBQSUNGTWN5YVp3Vy03cTk1bFBEb1JWc3lUWlFBZUxNc3g3RmlYUD…

RGEN — Frequently Asked Questions

What is the current share price of RGEN?

As of 2026-08-05 17:25 PDT, RGEN trades at $158.59 on NASDAQ/NYSE. Its 52-week range is $102.87 to $172.26.

What is the market capitalisation of RGEN?

RGEN has a market capitalisation of $8.93B on NASDAQ/NYSE.

What is the P/E ratio of RGEN?

RGEN trades at a trailing price-to-earnings (P/E) ratio of 184.41. Its price-to-book (P/B) ratio is 4.24.

What is the return on equity (ROE) of RGEN?

RGEN has a return on equity (ROE) of 2.32%. Its return on capital employed (ROCE) is 1.48%.

Is RGEN a good stock to buy?

This page provides a data-driven analysis of RGEN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space